Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

NCT00355199

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy
  • U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy
  • Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy
  • CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy
View all 16 locations
View Trial Details
Completed

A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma

NCT02472756

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Institute of Hematology Belgrade, Serbia
  • Clinical Center Bezanijska Kosa Belgrade, Serbia
  • Institute For Oncology Sremska Kamenica; Internal Medicine Department Kamenitz, Serbia
  • Clinical Center Kragujevac Kragujevac, Serbia
View Trial Details
Completed

First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance.

NCT00801281

Conditions
Chronic Disease, Disease Attributes, Follicular Lymphoma, +22 more
Locations
  • Podkarpacki Oncology Centre Brzozów, Poland
  • Voivodeship Hospital, Oncology Ward Elblag, Poland
  • Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology Gdansk, Poland
  • Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation Katowice, Poland
View Trial Details
Completed

Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

NCT00790036

Conditions
Diffuse Large B-cell Lymphoma, Hematologic Diseases, Hematologic Neoplasms, +12 more
Locations
  • Ironwood Cancer and Research Centers SC Chandler, Arizona, United States
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (3) La Jolla, California, United States
  • USC/Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisMedicalCenter(4) Los Angeles, California, United States
View all 202 locations
View Trial Details
Completed

A Safety Study of SGN-CD19A for Leukemia and Lymphoma

NCT01786096

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations
  • Children's Hospital of Alabama / University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 13 locations
View Trial Details

Related conditions